Teladoc Health ($TDOC) Q2 2026 Earnings Analysis — Revenue Miss and BetterHelp Guidance Cut Trigger After-Hours Crash
Teladoc Health ($TDOC) reported Q2 2026 revenue of $606.9 million, below the consensus estimate of $616 million and down 4% year-over-year. GAAP loss per share came in at -$0.21, but because the consensus estimate of -$0.23 was on an adjusted basis, a direct comparison is not appropriate. Integrated Care held up well, but the combination of deteriorating consumer (cash-pay) revenue at BetterHelp and lowered segment guidance triggered heavy selling in after-hours trading.
Earnings Scorecard
The Positives
The Negatives
What Management Said
"We continue to make progress on the priorities we believe matter most to Teladoc Health's long-term success. Our Q2 consolidated results were within the guidance range and reflected the differing dynamics across our two segments." — Chuck Divita, CEO
"We continue to expect 2026 insurance revenue to be within the previously communicated range, but we have lowered our BetterHelp segment revenue guidance to reflect an update to our cash-pay assumptions, including our prioritization of the growing insurance market." — Chuck Divita, CEO
Market Reaction and What to Watch Next
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.